No black box warning on record for Luxturna
As of the latest FDA labeling reviewed, Luxturna (VORETIGENE NEPARVOVEC-RZYL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Luxturna medicine page for the complete safety profile.